CDC Level 2 Alert: Yellow Fever Outbreaks in Burkina Faso, Côte d'Ivoire, and Ghana

What the CDC Notice Says

On 9 November 2026, the US Centers for Disease Control and Prevention published a Level 2 (Practice Enhanced Precautions) travel health notice for yellow fever activity in three West African countries:

Country Affected region cited
Burkina Faso Nando Region
Côte d'Ivoire (Ivory Coast) Bounkani Region
Ghana Upper West Region

The notice advises travelers to these areas to be vaccinated against yellow fever at least 10 days before travel and to take steps to prevent mosquito bites. None of the destinations commonly indexed on this site (e.g., Japan, Thailand, Korea, Türkiye, Egypt) are named in the alert, so this item is informational for travelers routing through or onward to West Africa.

Background in Brief

Yellow fever is a viral illness spread by infected mosquitoes that bite primarily during daylight hours. Most infections are mild or asymptomatic, but a minority progress to severe disease involving the liver and bleeding complications. There is no antiviral medicine for yellow fever; care is supportive. Because of this, prevention — vaccination plus bite avoidance — is the entire public-health strategy.

Separately from medical risk, yellow fever vaccination is also an entry requirement under the International Health Regulations for many countries in Africa and South America, and proof is recorded on the International Certificate of Vaccination or Prophylaxis (ICVP, the "yellow card"). Requirements are set by each government and can change during outbreaks, including for travelers merely transiting an affected country.

Practical Points for Travelers

  • Yellow fever vaccine is administered only at designated vaccination centers in most countries; appointments often need to be booked weeks ahead.
  • The 10-day interval before arrival exists for both immunologic and certificate-validity reasons.
  • Mosquito-bite precautions matter even for vaccinated travelers, because the same daytime-biting mosquitoes transmit dengue, chikungunya, and Zika.
  • Check the destination's current entry rules close to departure, as outbreak-related requirements may be updated.

Pharmacist's note: Yellow fever vaccine is a live attenuated product, so suitability is genuinely individual — age extremes, pregnancy and breastfeeding, thymus disorders or thymectomy, immunosuppressive therapy, and some egg or gelatin allergies all change the risk–benefit calculation, and a medical waiver is sometimes the appropriate route. That assessment belongs with a travel medicine clinician or an authorized yellow fever vaccination center, not with a pharmacy counter conversation or an online checklist. I would also flag timing: if you are stacking several travel vaccines, spacing and live-vaccine intervals need planning, so start the conversation 4–6 weeks out rather than the week before your flight. Keep your yellow card with your passport — a lost certificate is a border problem, not just a paperwork one.

Source: CDC Travelers' Health notice, published 9 November 2026. This summary is general public information and is not individual medical advice.

Primary sources

PharmTrip may include promotional content. Products and services are independently evaluated by a licensed pharmacist and rankings are never altered by advertiser requests. Information reflects what was current at the time of writing — please verify the latest terms on each provider's official site.